India's exports of generics have been growing at a rate of 24% per year over the last four years, and are set to continue this "explosive growth," an international conference has been told.

Europe's Innovative Medicines Initiative (IMI) has launched seven new projects, costing a combined 215 million euros, which will take on some of the biggest challenges in healthcare research.